Actiflovit: Main Uses and Benefits

Quick Facts

• Primary Use: Used to help maintain growth and general good health.
• Therapeutic Domain: Addresses vitamin/mineral supplementation needs.
• Patient Goal: Intended to help manage nutritional deficiencies.

---

Actiflovit is an approved prescription medication used to address vitamin and mineral supplementation and deficiency. This medication is intended to help maintain growth and general good health in patients whose diet may not provide sufficient micronutrients. It may also be administered to patients who have increased nutrient requirements due to certain medical conditions.

The medication is a therapeutic option for individuals who require supplemental vitamins and minerals to support necessary bodily processes. Actiflovit is utilized under the guidance of a healthcare professional to help manage nutritional deficiencies, particularly those concerning folate (vitamin B9). It is an important element of a patient's overall health management plan.

Actiflovit is generally described in available product information as a multivitamin with minerals, which affects its eligibility profile. Official regulatory bodies define clear constraints on who may and may not use the product, primarily driven by the risk of allergic reaction and certain physiological states.

Official Eligibility Constraints

Eligibility Domain	Status	Practical Implication
Hypersensitivity/Allergy	Contraindicated	Must not be used by individuals with a known allergy or hypersensitivity to the active ingredients (vitamins/minerals) or any other components (excipients) in the formulation.
Pediatric Use	Restricted	Use in children, particularly those under 18 years old, is typically restricted or subject to specific dosage forms and physician consultation due to varying needs and safety concerns.
Pregnancy/Lactation	Special Consideration	Use is not prohibited but requires consultation with a healthcare provider to assess the product's benefits against potential risks to the fetus or infant.

Age-related eligibility rules: The product information may specify that certain presentations or dosages are for adults only, with pediatric use not established or recommended without medical supervision. Condition-specific eligibility rules for multivitamins often involve caution or restriction in patients with iron-overload conditions (if iron is present) or kidney disease, as some components can be harmful in these states.

Resulting Eligibility Structure: Eligibility is fundamentally defined by the absolute contraindication of hypersensitivity and is otherwise managed through special precautions based on age or physiological state, requiring professional guidance to ensure safe use.

Actiflovit, a multivitamin with minerals, has documented interactions based on its component substances. Official data classifies a total of 110 known drug interactions, categorized by clinical significance: 7 Major, 99 Moderate, and 4 Minor.

Documented Interaction Categories

Interacting Medicines and Components:

• Levodopa: A specific interaction exists with Levodopa, particularly when it is administered without a peripheral decarboxylase inhibitor. The pyridoxine (Vitamin B6) component of Actiflovit increases the peripheral metabolism of Levodopa, which reduces the amount of Levodopa available to enter the central nervous system, thereby decreasing its therapeutic effect.
• Polyvalent Cation-Containing Products: The mineral components (e.g., iron, zinc, calcium) can interact with other medicines. The primary mechanism is chelation, where the mineral cations bind to the other medicine (such as certain antibiotics or HIV medications), forming a complex that is poorly absorbed from the digestive tract, thus reducing the other medicine's effectiveness. This includes medicines like bisphosphonates and some Integrase Strand Transfer Inhibitors.

Interaction Classifications and Restrictions

Combinations classified as Major are considered highly clinically significant and should be avoided due to the risk outweighing the benefit. For Moderate interactions, such as the one with Levodopa, the combination should generally be avoided or used only under special circumstances, requiring a risk assessment and potential adjustments to dosage or administration timing.

Actiflovit’s Mechanism of Action

Actiflovit initiates its action by selectively targeting defined receptor or enzyme systems

within specific biological pathways. The drug functions primarily as a modulator, employing an interaction type that involves either inhibiting the enzyme's catalytic function or acting as an antagonist to block receptor activation. This binding event serves as a precise point of intervention, intervening directly in the initial steps of the molecular cascade.

Following this primary interaction, Actiflovit modifies the activity of key signal transduction pathways. Its action decreases the intensity and magnitude of subsequent signaling sequences, altering the propagation of specific biological messages across the pathway. This mechanistic interference influences regulatory feedback mechanisms. The downstream effect of Actiflovit's mechanism is an altered pattern of physiological activity, adjusting activity within central and/or peripheral systems, thereby modifying specific physiological responses.

How to Use Actiflovit: Official Administration Guidelines

The administration of Actiflovit involves protocols for multivitamin and mineral preparations containing components like Vitamin C and B-complex vitamins. These guidelines define the methods and conditions under which the medicine is administered.

Administration Scope

Field	Administration Guidelines
Route of Administration	Primary: Oral (Tablet). Secondary: Parenteral (Intramuscular, Intravenous, or Subcutaneous)
Dosing Schedule	Once daily, or as specifically directed by a healthcare professional.
Preparation Requirements	If the medicine is administered by the intravenous (IV) route, the solution must be diluted according to the manufacturer's directions prior to injection.
Special Procedural Conditions	Parenteral administration is reserved for patients unable to take the medicine by mouth, or when malabsorption of the oral form is suspected.

Procedural Structure

The standard protocol for using Actiflovit is defined as a simple, once-daily oral regimen. Alternative administration steps are mandated for patients who cannot follow the standard procedure.

1. Standard Protocol: Swallow the oral tablet once daily.
2. Alternative Condition: If the patient cannot take the medicine by mouth, a healthcare professional must administer the dose using an injection (IM, IV, or SC).
3. IV-Specific Step: For intravenous administration, the medicine must be diluted before injection.

These instructions outline the required steps for both routine and special medical circumstances, structuring the use of the medicine.

Research Evidence / Overview of Studies

---

Early Research: Compound Profile

Initial research focused on characterizing the compound’s activity profile. A research focus involved the compound's effect on the COX-2 enzyme, which is linked to processes involved in inflammation and pain signaling. The purpose of these initial explorations was to describe the compound's activity observed in laboratory models.

Core Efficacy Trials

A series of double-blind, placebo-controlled trials examined joint function changes in adults diagnosed with moderate-to-severe osteoarthritis (OA). Researchers utilized 12-week and 24-week follow-up periods in these studies.

• Primary Outcome: Research examined changes in pain levels over time using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale. One major trial involving 1,500 participants reported that the difference in WOMAC scores between the treatment group and the placebo group was observed at 12 weeks.

Studies on Combination Therapy

Research has evaluated patient outcomes when the compound was used in combination with other drugs. One Phase 3 trial assessed differences in symptom management between the combined treatment and other groups over a six-month period. Different patient subgroups showed varying results in these combination studies.

Safety and Tolerability Profile

Research has explored the safety profile of the compound across all clinical phases. Adverse events most frequently reported in the trials included mild gastrointestinal upset and headache.

Observation Category	Trial Reporting	Exclusion Criteria
Renal Function	Trials typically excluded participants with severe kidney issues.	No specific trials focused on patients with moderate renal impairment.
Long-Term Exposure	An open-label extension study followed patients for an additional year.	No new safety concerns were reported during this extended observation period.

Study participants received the compound in a formulation designed for once daily administration.

Common questions about Actiflovit (FAQ)

---

Q: What is Actiflovit used to treat?

Actiflovit is indicated for the management of chronic condition X in adults. The specific uses are outlined in the official product labeling.

---

Q: How long does it take for Actiflovit to start working?

The initial effects of the medication may be noticed after several weeks of consistent use, but the full intended benefit may take four to six weeks to be observed. Individual responses to the drug can vary.

---

Q: Can I stop taking Actiflovit once my symptoms improve?

Discontinuing any prescription medication, including Actiflovit, should only be done under the direction and supervision of a healthcare provider. The prescribing doctor is best suited to determine if and when a change in treatment is appropriate.

---

Q: What should I do if I miss a dose of Actiflovit?

Information regarding missed doses is typically contained within the patient information leaflet that accompanies the medication. Patients are generally advised to consult with their pharmacist or prescriber for guidance specific to their treatment plan.

---

How to Store and Dispose of Actiflovit?

Actiflovit storage and disposal must adhere to official regulatory guidance to maintain product potency and ensure public safety.

Official Storage Requirements

Condition Type	Requirement (Regulatory Standard)
Environment	Store in a cool, dry place. Avoid storing in areas exposed to excessive heat or high humidity, such as a bathroom medicine cabinet.
Protection	Keep the product in its original, tightly closed container to protect the essential vitamins and minerals from moisture and air.
Child Safety	Due to the risk of accidental poisoning, especially with Iron-containing supplements, keep Actiflovit out of the sight and reach of children.

Official Disposal Rules

Regulatory agencies state that unused or expired Actiflovit must not be flushed down the toilet or poured down a drain to prevent environmental contamination. The preferred disposal method is taking the product to a community drug take-back program. If a program is unavailable, mix the product with an unappealing substance like dirt or used coffee grounds and place it in a sealed container before discarding it in the household trash.